Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin.
Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin.
复制标题
DOI:
10.1186/2044-5040-4-2
复制
发表时间:
2014-01-22
期刊:
影响因子:
4.9
通讯作者:
Arany Z
中科院分区:
文献类型:
--
作者:
Chan MC;Rowe GC;Raghuram S;Patten IS;Farrell C;Arany Z
Duchenne muscle dystrophy (DMD) afflicts 1 million boys in the US and has few effective treatments. Constitutive transgenic expression of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator (PGC)-1α improves skeletal muscle function in the murine “mdx” model of DMD, but how this occurs, or whether it can occur post-natally, is not known. The leading mechanistic hypotheses for the benefits conferred by PGC-1α include the induction of utrophin, a dystrophin homolog, and/or induction and stabilization of the neuromuscular junction. The effects of transgenic overexpression of PGC-1β, a homolog of PGC-1α in mdx mice was examined using different assays of skeletal muscle structure and function. To formally test the hypothesis that PGC-1α confers benefit in mdx mice by induction of utrophin and stabilization of neuromuscular junction, PGC-1α transgenic animals were crossed with the dystrophin utrophin double knock out (mdx/utrn-/-) mice, a more severe dystrophic model. Finally, we also examined the effect of post-natal induction of skeletal muscle-specific PGC-1α overexpression on muscle structure and function in mdx mice. We show here that PGC-1β does not induce utrophin or other neuromuscular genes when transgenically expressed in mouse skeletal muscle. Surprisingly, however, PGC-1β transgenesis protects as efficaciously as PGC-1α against muscle degeneration in dystrophin-deficient (mdx) mice, suggesting that alternate mechanisms of protection exist. When PGC-1α is overexpressed in mdx/utrn-/- mice, we find that PGC-1α dramatically ameliorates muscle damage even in the absence of utrophin. Finally, we also used inducible skeletal muscle-specific PGC-1α overexpression to show that PGC-1α can protect against dystrophy even if activated post-natally, a more plausible therapeutic option. These data demonstrate that PGC-1α can improve muscle dystrophy post-natally, highlighting its therapeutic potential. The data also show that PGC-1α is equally protective in the more severely affected mdx/utrn-/- mice, which more closely recapitulates the aggressive progression of muscle damage seen in DMD patients. The data also identify PGC-1β as a novel potential target, equally efficacious in protecting against muscle dystrophy. Finally, the data also show that PGC-1α and PGC-1β protect against dystrophy independently of utrophin or of induction of the neuromuscular junction, indicating the existence of other mechanisms.
登录
查看更多内容
影响因子:
4.9
作者:
Jahnke VE;Van Der Meulen JH;Johnston HK;Ghimbovschi S;Partridge T;Hoffman EP;Nagaraju K
通讯作者:
Nagaraju K
影响因子:
5.8
作者:
Bornman, L;Rossouw, H;Polla, BS
通讯作者:
Polla, BS
影响因子:
5.5
作者:
Angus, LM;Chakkalakal, JV;Jasmin, BJ
通讯作者:
Jasmin, BJ
影响因子:
6.9
作者:
Golde, WT;Gollobin, P;Rodriguez, LL
通讯作者:
Rodriguez, LL
影响因子:
64.5
作者:
Grady, RM;Teng, HB;Sanes, JR
通讯作者:
Sanes, JR